Literature DB >> 16775460

Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia.

Kai M Schmidt-Ott1, Kiyoshi Mori, Avtandil Kalandadze, Jau-Yi Li, Neal Paragas, Thomas Nicholas, Prasad Devarajan, Jonathan Barasch.   

Abstract

PURPOSE OF REVIEW: Neutrophil gelatinase-associated lipocalin (NGAL) is a member of the lipocalin superfamily of carrier proteins. NGAL is the first known mammalian protein which specifically binds organic molecules called siderophores, which are high-affinity iron chelators. Here, we review the expression, siderophore-dependent biological activities and clinical significance of NGAL in epithelial development and in kidney disease. RECENT
FINDINGS: NGAL expression is rapidly induced in the nephron in response to renal epithelial injury. This has led to the establishment of NGAL assays that detect renal damage in the human. Additionally, only when complexed with siderophore and iron as a trimer, NGAL induces mesenchymal-epithelial transition (or nephron formation) in embryonic kidney in vitro and protects adult kidney from ischemia-reperfusion injury in vivo. While the structure of the NGAL: siderophore: iron complex has thus far only been solved for bacterially synthesized siderophores, new evidence suggests the presence of mammalian siderophore-like molecules.
SUMMARY: NGAL is rapidly and massively induced in renal epithelial injury and NGAL: siderophore: iron complexes may comprise a physiological renoprotective mechanism. The data have implications for the diagnosis and treatment of acute renal injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775460     DOI: 10.1097/01.mnh.0000232886.81142.58

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  83 in total

1.  Bioinorganic chemistry: Getting a grip on iron.

Authors:  Caroline Philpott
Journal:  Nat Chem Biol       Date:  2010-08       Impact factor: 15.040

Review 2.  Siderophore-based iron acquisition and pathogen control.

Authors:  Marcus Miethke; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

3.  Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia.

Authors:  Sun Min Kim; Joong Shin Park; Errol R Norwitz; Hee Jung Jung; Byoung Jae Kim; Chan-Wook Park; Jong Kwan Jun
Journal:  Reprod Sci       Date:  2013-02-25       Impact factor: 3.060

Review 4.  Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.

Authors:  Joseph L Alge; John M Arthur
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

5.  Emerging urinary biomarkers in the diagnosis of acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Expert Opin Med Diagn       Date:  2008-04

6.  NGAL is an early predictive biomarker of contrast-induced nephropathy in children.

Authors:  Russel Hirsch; Catherine Dent; Holly Pfriem; Janene Allen; Robert H Beekman; Qing Ma; Sudha Dastrala; Michael Bennett; Mark Mitsnefes; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

Review 7.  Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease.

Authors:  Prasad Devarajan
Journal:  Scand J Clin Lab Invest Suppl       Date:  2008

8.  Neutrophil gelatinase-associated lipocalin expresses antimicrobial activity by interfering with L-norepinephrine-mediated bacterial iron acquisition.

Authors:  Marcus Miethke; Arne Skerra
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Authors:  Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2009-12-25       Impact factor: 29.983

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.